1.What is it?
The only current responsive oxygen therapy device with precise, intelligent flow control using the new Binary Actuation Technology (BAT).
2. Why is it important?
31% patients do not remain within intended range of saturation when on emergency oxygen.¹ This leads do 2,000 – 4, 000 unnecessary deaths in the UK from inadequate oxygenation. ²
This device has capacity to be used in a high range of respiratory and non- respiratory cases:
- anaemia
- lung cancer
- anaphylaxis
- post surgery
- emergency medicine
IMOD can reduce consumption of oxygen by 66% with it’s breath synchronised mode which only delivers oxygen on inhalation which could reduce annual hospital spending by £200, 000 per annum. ³
3. How does it work?
IMOD automatically monitors and adjusts flow control to provide immediate therapy even at minimal inhalation.
- tracks patient’s breathing pattern
- deliver oxygen continuously or only on inhalation (choose mode)
- oxygen delivered from piped supply or bottles (versatile) – up to 15l/ min
- additional features include measurements of Sp02 and vitals
IMOD is compact and portable but does require charging which is stated to run for over 24 hours on a single charge.
Oxygen delivery is compatible with:
- non- rebreather face mask
- Venturi face mask
- standard face mask
- nasal cannula
References
1. British Thoracic Society Emergency Oxygen Audit Report National Audit Period. Ronan O’Driscoll. 15 August – 1 November 2015 https://www.brit-thoracic.org.uk/document-library/audit-and-quality-improvement/audit-reports/bts-emergency-oxygen-audit-report-2015/
2. Data on file – IMOS: Expert medical Reactions. Received September 2017.
3. IMOS Device: Clinical Insight and Technical Validation Report. Cambridge University Hospitals NHS. June 2014.
All images from this article belong to Camcon Medical
